Endothelin-1 release from the lamb ductus arteriosus: are carbon monoxide and nitric oxide regulatory agents?
We have proposed that endothelin-1 (ET-1), formed through the activation of a cytochrome P450 (CYP450)-based monooxygenase reaction, is important for generation of contractile tone in the ductus arteriosus and, consequently, for closure of the vessel at birth. The present investigation was undertaken to ascertain, using an isolated ductus preparation from near-term fetal lambs, whether carbon monoxide (CO) and nitric oxide (NO) qualify as regulators of the CYP450/ET-1 system. Preparations released ET-1 at rest and its amount showed no significant reduction following removal of the endothelium. Basal release was not changed by the NO synthesis inhibitor, N(G)-nitro-L-arginine methylester (L-NAME, 100 microM), nor by agents altering cyclic GMP content (i.e. increase; ONO-1505, 1 microM) and action (i.e. decrease; LY-83583, 10 microM). These findings extend previous work showing no effect of the CO synthesis inhibitor zinc protoporphyrin IX (ZnPP, 10 microM) under the same conditions (10). Conversely, both CO (65 microM) and the NO donor, sodium nitroprusside (SNP, 10 microM), curtailed ET-1 release. ET-1 release was increased by oxygen and reduced by pyrogens (endotoxin and IL-1, both at 100 ng mL(-1)). The endotoxin effect tended to be reversed by L-NAME and ZnPP, used singly or in combination. We conclude that ET-1 is formed naturally in the ductus and that its formation may change in response to physiological (oxygen) and pathophysiological (pyrogens) stimuli. Endogenous CO and NO, however, appear to have little or no role as ET-1 regulators.
Coceani
F
F
Integrative Biology Programme, Research Institute, The Hospital for Sick Children, Toronto, Ont., Canada. coceani@sssup.it
Kelsey
L
L
D000634:Aminoquinolines / Q000494:pharmacology; D000818:Animals; D002248:Carbon Monoxide / Q000502:physiology*; D000242:Cyclic AMP / Q000096:biosynthesis; D004373:Ductus Arteriosus / Q000187:drug effects / Q000196:embryology / Q000378:metabolism* / Q000502:physiology; D019332:Endothelin-1 / Q000378:metabolism*; D004731:Endotoxins / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D007375:Interleukin-1 / Q000494:pharmacology; D008698:Mesylates / Q000494:pharmacology; D009126:Muscle Relaxation / Q000502:physiology; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009569:Nitric Oxide / Q000502:physiology*; D009842:Oligopeptides / Q000494:pharmacology; D010100:Oxygen / Q000378:metabolism; D010880:Piperidines / Q000494:pharmacology; D012756:Sheep
D000634:Aminoquinolines; D019332:Endothelin-1; D004731:Endotoxins; D007093:Imidazoles; D007375:Interleukin-1; D008698:Mesylates; C404564:ONO 1505; D009842:Oligopeptides; D010880:Piperidines; D009569:Nitric Oxide; C086539:BQ 788; D002248:Carbon Monoxide; C041715:6-anilino-5,8-quinolinedione; D000242:Cyclic AMP; D010100:Oxygen; D019331:NG-Nitroarginine Methyl Ester